Table 3 Initial anaphylactic reaction to a bee field sting compared between patients experiencing an adverse reaction (AR) to immunotherapy and those without complications (NC)
All patients | AR | NC | ||
|---|---|---|---|---|
No. of patients | 19 | 3 | 16 | P |
Median grade of anaphylactic reaction to initial field sting | 2 | 2 | 2 | n.s |
No. (%) of patients with dermal symptoms | 19 (100.0) | 3 (100.0) | 16 (100.0) | n.s |
(95% CI) | (100 to 100) | (100 to 100) | (100 to 100) | |
No. (%) of patients with gastrointestinal symptoms | 6 (31.6) | 1 (33.3) | 5 (31.3) | n.s |
(95% CI) | (12.6 to 56.6) | (0.8 to 90.6) | (11.0 to 58.7) | |
No. (%) of patients with respiratory symptoms | 13 (68.4) | 2 (66.7) | 11 (68.8) | n.s |
(95% CI) | (43.5 to 87.4) | (9.4 to 99.2) | (41.3 to 89.0) | |
No. (%) of patients with cardiovascular symptoms | 10 (52.6) | 1 (33.3) | 9 (56.3) | n.s |
(95% CI) | (28.9 to 75.6) | (0.8 to 90.6) | (29.9 to 80.3) |